{"id":"https://openalex.org/W2158240950","doi":"https://doi.org/10.1111/j.1742-7843.2005.pto960308.x","title":"Application of Full Physiological Models for Pharmaceutical Drug Candidate Selection and Extrapolation of Pharmacokinetics to Man","display_name":"Application of Full Physiological Models for Pharmaceutical Drug Candidate Selection and Extrapolation of Pharmacokinetics to Man","alternate_titles":[],"publication_year":2005,"publication_date":"2005-02-25","ids":{"openalex":"https://openalex.org/W2158240950","doi":"https://doi.org/10.1111/j.1742-7843.2005.pto960308.x","mag":"2158240950","pmid":"https://pubmed.ncbi.nlm.nih.gov/15733214"},"language":"en","primary_location":{"id":"doi:10.1111/j.1742-7843.2005.pto960308.x","doi":"https://doi.org/10.1111/j.1742-7843.2005.pto960308.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-7843.2005.pto960308.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2005.pto960308.x","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic &amp; Clinical Pharmacology &amp; Toxicology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2158240950"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2005.pto960308.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055401474","display_name":"Neil John Parrott","orcid":"https://orcid.org/0000-0001-6821-7714","observed_orcids":["https://orcid.org/0000-0001-6821-7714"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Neil Parrott","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Pharma Research Non-Clinical Development, Non-Clinical Drug Safety, Bau 70/130, Grenzacherstrasse, CH-4002 Basel, Switzerland. neil_john.parrott@roche.com","F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Pharma Research Non-Clinical Development, Non-Clinical Drug Safety, Basel Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Pharma Research Non-Clinical Development, Non-Clinical Drug Safety, Bau 70/130, Grenzacherstrasse, CH-4002 Basel, Switzerland. neil_john.parrott@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Pharma Research Non-Clinical Development, Non-Clinical Drug Safety, Basel Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016745322","display_name":"Hannah M. Jones","orcid":"https://orcid.org/0000-0003-2711-4545","observed_orcids":["https://orcid.org/0000-0003-2711-4545"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hannah Jones","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Pharma Research Non-Clinical Development, Non-Clinical Drug Safety, Basel Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Pharma Research Non-Clinical Development, Non-Clinical Drug Safety, Basel Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008993913","display_name":"Nicolas Paquereau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicolas Paquereau","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Pharma Research Non-Clinical Development, Non-Clinical Drug Safety, Basel Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Pharma Research Non-Clinical Development, Non-Clinical Drug Safety, Basel Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044090708","display_name":"Thierry Lav\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thierry Lav\u00e9","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Pharma Research Non-Clinical Development, Non-Clinical Drug Safety, Basel Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Pharma Research Non-Clinical Development, Non-Clinical Drug Safety, Basel Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5055401474"],"corresponding_institution_ids":["https://openalex.org/I118019719"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":6.0979,"has_fulltext":true,"cited_by_count":97,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.9611335,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"96","issue":"3","first_page":"193","last_page":"199"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.6615999937057495,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.6615999937057495,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.11429999768733978,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.08229999989271164,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/physiologically-based-pharmacokinetic-model","display_name":"physiologically based pharmacokinetic modeling","score":0.9490000009536743},{"id":"https://openalex.org/keywords/drug-candidate-selection","display_name":"drug candidate selection","score":0.9190000295639038},{"id":"https://openalex.org/keywords/preclinical-drug-development","display_name":"preclinical drug development","score":0.8989999890327454},{"id":"https://openalex.org/keywords/dose-selection","display_name":"dose selection","score":0.7279999852180481},{"id":"https://openalex.org/keywords/in-silico-modeling","display_name":"in silico modeling","score":0.4320000112056732}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7235243320465088},{"id":"https://openalex.org/C132459708","wikidata":"https://www.wikidata.org/wiki/Q744069","display_name":"Extrapolation","level":2,"score":0.6298770904541016},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.6258200407028198},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6073015928268433},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5074059367179871},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4569835960865021},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2946070432662964},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.14539647102355957},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.13854745030403137},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.09393802285194397}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010599","descriptor_name":"Pharmacokinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1742-7843.2005.pto960308.x","doi":"https://doi.org/10.1111/j.1742-7843.2005.pto960308.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-7843.2005.pto960308.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2005.pto960308.x","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic &amp; Clinical Pharmacology &amp; Toxicology","raw_type":"journal-article"},{"id":"pmid:15733214","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15733214","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic & clinical pharmacology & toxicology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1742-7843.2005.pto960308.x","doi":"https://doi.org/10.1111/j.1742-7843.2005.pto960308.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-7843.2005.pto960308.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2005.pto960308.x","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic &amp; Clinical Pharmacology &amp; Toxicology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2158240950.pdf","grobid_xml":"https://content.openalex.org/works/W2158240950.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1550485225","https://openalex.org/W1979813244","https://openalex.org/W2009858196","https://openalex.org/W2013258146","https://openalex.org/W2019306159","https://openalex.org/W2051674641","https://openalex.org/W2079192244","https://openalex.org/W2140474672","https://openalex.org/W2149429360","https://openalex.org/W2261065881"],"related_works":["https://openalex.org/W158667478","https://openalex.org/W2013258146","https://openalex.org/W2549687751","https://openalex.org/W4233263263","https://openalex.org/W4389607752","https://openalex.org/W4206253518","https://openalex.org/W1966821331","https://openalex.org/W1979813244","https://openalex.org/W2067396426","https://openalex.org/W7095113363"],"abstract_inverted_index":{"This":[0],"paper":[1],"describes":[2],"how":[3,49],"we":[4],"are":[5,33,86],"applying":[6],"physiologically":[7],"based":[8],"models":[9,51,126],"of":[10,22,74,102,105,124],"pharmacokinetics":[11],"as":[12,127],"an":[13],"integrated":[14],"part":[15],"in":[16,41,64],"the":[17,37,72,95,98,103,106],"research":[18,43],"and":[19,27,30,36,77,129],"preclinical":[20],"development":[21],"novel":[23],"drugs.":[24],"The":[25],"modeling":[26],"simulation":[28],"tools":[29],"techniques":[31],"used":[32],"briefly":[34],"reviewed":[35],"strategy":[38],"for":[39],"application":[40,61],"drug":[42],"is":[44],"described.":[45],"Three":[46],"examples":[47,99],"illustrate":[48,100],"such":[50],"may":[52],"be":[53,117],"applied":[54],"at":[55,94],"different":[56],"stages":[57],"ranging":[58],"from":[59],"early":[60],"prior":[62,80],"to":[63,71,81,90,109,135],"vivo":[65],"studies,":[66],"through":[67],"clinical":[68,82],"candidate":[69],"selection":[70,79],"estimation":[73],"human":[75],"kinetics":[76],"dose":[78],"studies.":[83],"Although":[84],"there":[85],"obvious":[87],"restrictions":[88],"related":[89],"limited":[91],"input":[92],"data":[93],"earlier":[96],"stages,":[97],"some":[101],"advantages":[104,115],"approach":[107],"compared":[108],"other":[110],"more":[111,121],"empirical":[112],"methods.":[113],"These":[114],"will":[116],"fully":[118],"exploited":[119],"with":[120],"widespread":[122],"use":[123],"physiological":[125],"powerful":[128],"user-friendly":[130],"software":[131],"make":[132],"them":[133],"accessible":[134],"non-specialists.":[136]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2158240950","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
